Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Glioblastoma models driven by different mutations converge to the proneural subtype.

Alessandrini F, Ceresa D, Appolloni I, Pagani F, Poliani PL, Marubbi D, Malatesta P.

Cancer Lett. 2019 Nov 13. pii: S0304-3835(19)30565-8. doi: 10.1016/j.canlet.2019.11.010. [Epub ahead of print]

PMID:
31733287
2.

αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion.

Vannini A, Leoni V, Barboni C, Sanapo M, Zaghini A, Malatesta P, Campadelli-Fiume G, Gianni T.

Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20141-20150. doi: 10.1073/pnas.1901931116. Epub 2019 Sep 16. Erratum in: Proc Natl Acad Sci U S A. 2019 Oct 14;:.

3.

Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells.

Ceresa D, Alessandrini F, Bosio L, Marubbi D, Reverberi D, Malatesta P, Appolloni I.

Int J Mol Sci. 2019 Aug 18;20(16). pii: E4028. doi: 10.3390/ijms20164028.

4.

Functional characterization of p.Pro409His variant in HNF1A, a hypomorphic mutation involved in pancreatic β-cell dysfunction.

Nocera D, Menniti M, Belviso S, Bond HM, Lanzillotta D, Spoleti CB, Guagliardi MR, Malatesta P, Trapasso F, Irace C, Perrotti N, Iuliano R.

Acta Diabetol. 2019 Aug;56(8):883-888. doi: 10.1007/s00592-019-01298-6. Epub 2019 Apr 9.

PMID:
30963309
5.

Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model.

Alessandrini F, Menotti L, Avitabile E, Appolloni I, Ceresa D, Marubbi D, Campadelli-Fiume G, Malatesta P.

Oncogene. 2019 Jun;38(23):4467-4479. doi: 10.1038/s41388-019-0737-2. Epub 2019 Feb 12.

PMID:
30755732
6.

TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways.

Venuto S, Castellana S, Monti M, Appolloni I, Fusilli C, Fusco C, Pucci P, Malatesta P, Mazza T, Merla G, Micale L.

Biochim Biophys Acta Gen Subj. 2019 Feb;1863(2):491-501. doi: 10.1016/j.bbagen.2018.12.001. Epub 2018 Dec 5.

PMID:
30528352
7.

Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting.

Appolloni I, Alessandrini F, Ceresa D, Marubbi D, Gambini E, Reverberi D, Loiacono F, Malatesta P.

Cancer Lett. 2019 Feb 1;442:213-221. doi: 10.1016/j.canlet.2018.10.006. Epub 2018 Oct 9.

PMID:
30312732
8.

HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses.

Menotti L, Avitabile E, Gatta V, Malatesta P, Petrovic B, Campadelli-Fiume G.

Viruses. 2018 Jun 30;10(7). pii: E352. doi: 10.3390/v10070352.

9.

Noninvasive Monitoring of Glioma Growth in the Mouse.

Alessandrini F, Ceresa D, Appolloni I, Marubbi D, Malatesta P.

J Cancer. 2016 Aug 12;7(13):1791-1797. eCollection 2016.

10.

Platelet derived growth factor B gene expression in the Xenopus laevis developing central nervous system.

Giannetti K, Corsinovi D, Rossino C, Appolloni I, Malatesta P, Ori M.

Int J Dev Biol. 2016;60(4-6):175-9. doi: 10.1387/ijdb.160045mo.

11.

Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network.

Signaroldi E, Laise P, Cristofanon S, Brancaccio A, Reisoli E, Atashpaz S, Terreni MR, Doglioni C, Pruneri G, Malatesta P, Testa G.

Nat Commun. 2016 Feb 29;7:10753. doi: 10.1038/ncomms10753.

12.

A cryptic balanced translocation (5;17), a puzzle revealed through a critical evaluation of the pedigree and a FISH focused on candidate loci suggested by the phenotype.

Primerano A, Colao E, Villella C, Nocera MD, Ciambrone A, Luciano E, D'Antona L, Vismara MFM, Loddo S, Novelli A, Perrotti N, Malatesta P.

Mol Cytogenet. 2015 Sep 2;8:70. doi: 10.1186/s13039-015-0172-1. eCollection 2015.

13.

A cadherin switch underlies malignancy in high-grade gliomas.

Appolloni I, Barilari M, Caviglia S, Gambini E, Reisoli E, Malatesta P.

Oncogene. 2015 Apr 9;34(15):1991-2002. doi: 10.1038/onc.2014.122. Epub 2014 May 26.

PMID:
24858041
14.

Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma.

Favaro R, Appolloni I, Pellegatta S, Sanga AB, Pagella P, Gambini E, Pisati F, Ottolenghi S, Foti M, Finocchiaro G, Malatesta P, Nicolis SK.

Cancer Res. 2014 Mar 15;74(6):1833-44. doi: 10.1158/0008-5472.CAN-13-1942. Epub 2014 Mar 5.

15.

A case of premature ovarian failure in a 33-year-old woman.

Colao E, Granata T, Vismara MF, Bombardiere F, Nocera D, Luciano E, Perrotti N, Malatesta P.

Case Rep Genet. 2013;2013:573841. doi: 10.1155/2013/573841. Epub 2013 Jan 29.

16.

Radial glia - from boring cables to stem cell stars.

Malatesta P, Götz M.

Development. 2013 Feb 1;140(3):483-6. doi: 10.1242/dev.085852.

17.

Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.

Appolloni I, Curreli S, Caviglia S, Barilari M, Gambini E, Pagano A, Malatesta P.

Int J Mol Sci. 2012 Nov 12;13(11):14667-78. doi: 10.3390/ijms131114667.

18.

A novel collection of snRNA-like promoters with tissue-specific transcription properties.

Garritano S, Gigoni A, Costa D, Malatesta P, Florio T, Cancedda R, Pagano A.

Int J Mol Sci. 2012;13(9):11323-32. doi: 10.3390/ijms130911323. Epub 2012 Sep 11.

19.

Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells.

Amato R, Scumaci D, D'Antona L, Iuliano R, Menniti M, Di Sanzo M, Faniello MC, Colao E, Malatesta P, Zingone A, Agosti V, Costanzo FS, Mileo AM, Paggi MG, Lang F, Cuda G, Lavia P, Perrotti N.

Oncogene. 2013 Sep 19;32(38):4572-8. doi: 10.1038/onc.2012.470. Epub 2012 Oct 29.

PMID:
23108393
20.

Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice.

Reisoli E, Gambini E, Appolloni I, Gatta V, Barilari M, Menotti L, Malatesta P.

Cancer Gene Ther. 2012 Nov;19(11):788-95. doi: 10.1038/cgt.2012.62. Epub 2012 Sep 21.

PMID:
22996742
21.

Antagonistic modulation of gliomagenesis by Pax6 and Olig2 in PDGF-induced oligodendroglioma.

Appolloni I, Calzolari F, Barilari M, Terrile M, Daga A, Malatesta P.

Int J Cancer. 2012 Oct 1;131(7):E1078-87. doi: 10.1002/ijc.27606. Epub 2012 May 17.

22.

Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma.

Gambini E, Reisoli E, Appolloni I, Gatta V, Campadelli-Fiume G, Menotti L, Malatesta P.

Mol Ther. 2012 May;20(5):994-1001. doi: 10.1038/mt.2012.22. Epub 2012 Feb 21.

23.

Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.

Favoni RE, Daga A, Malatesta P, Florio T.

Br J Pharmacol. 2012 May;166(2):532-53. doi: 10.1111/j.1476-5381.2012.01873.x. Review.

24.

Advances in drug design based on the amino Acid approach: taurine analogues for the treatment of CNS diseases.

Chung MC, Malatesta P, Bosquesi PL, Yamasaki PR, Santos JL, Vizioli EO.

Pharmaceuticals (Basel). 2012 Oct 23;5(10):1128-46. doi: 10.3390/ph5101128.

25.

Identification of a new mutation in the gene coding for hairless protein responsible for alopecia universalis: The importance of direct gene sequencing.

Nucara S, Colao E, Mangone G, Baudi F, Fabiani F, Nocera D, Passafaro G, Longo T, Laria AE, Malatesta P, Amato R, Trapasso F, Perrotti N.

Dermatol Online J. 2011 Jan 15;17(1):3.

26.

PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2.

Terrile M, Appolloni I, Calzolari F, Perris R, Tutucci E, Malatesta P.

BMC Cancer. 2010 Oct 12;10:550. doi: 10.1186/1471-2407-10-550.

27.

Recent insights into PDGF-induced gliomagenesis.

Calzolari F, Malatesta P.

Brain Pathol. 2010 May;20(3):527-38. doi: 10.1111/j.1750-3639.2009.00335.x. Epub 2009 Sep 25. Review.

PMID:
19832839
28.

PDGF-B induces a homogeneous class of oligodendrogliomas from embryonic neural progenitors.

Appolloni I, Calzolari F, Tutucci E, Caviglia S, Terrile M, Corte G, Malatesta P.

Int J Cancer. 2009 May 15;124(10):2251-9. doi: 10.1002/ijc.24206. Erratum in: Int J Cancer. 2011 Jan 15;128(2):e1.

29.

Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis.

Calzolari F, Appolloni I, Tutucci E, Caviglia S, Terrile M, Corte G, Malatesta P.

Neoplasia. 2008 Dec;10(12):1373-82, following 1382.

30.

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, Ravetti GL, Zona GL, Daga A, Corte G.

Stem Cells. 2009 Jan;27(1):40-8. doi: 10.1634/stemcells.2008-0493.

31.

Prospective isolation of functionally distinct radial glial subtypes--lineage and transcriptome analysis.

Pinto L, Mader MT, Irmler M, Gentilini M, Santoni F, Drechsel D, Blum R, Stahl R, Bulfone A, Malatesta P, Beckers J, Götz M.

Mol Cell Neurosci. 2008 May;38(1):15-42. doi: 10.1016/j.mcn.2008.01.012. Epub 2008 Feb 1.

PMID:
18372191
32.

Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor.

Balakrishnan A, Wang L, Li X, Ohman-Strickland P, Malatesta P, Fan H.

Microbiol Res. 2009;164(3):338-46. Epub 2007 Oct 23.

33.

Radial glia and neural stem cells.

Malatesta P, Appolloni I, Calzolari F.

Cell Tissue Res. 2008 Jan;331(1):165-78. Epub 2007 Sep 11. Review.

PMID:
17846796
34.

Six3 controls the neural progenitor status in the murine CNS.

Appolloni I, Calzolari F, Corte G, Perris R, Malatesta P.

Cereb Cortex. 2008 Mar;18(3):553-62. Epub 2007 Jun 18.

PMID:
17576749
35.

Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray.

Bertani N, Malatesta P, Volpi G, Sonego P, Perris R.

J Cell Sci. 2005 Sep 1;118(Pt 17):3925-36. Epub 2005 Aug 9.

36.

Functional analysis of R75Q mutation in the gene coding for Connexin 26 identified in a family with nonsyndromic hearing loss.

Piazza V, Beltramello M, Menniti M, Colao E, Malatesta P, Argento R, Chiarella G, Gallo LV, Catalano M, Perrotti N, Mammano F, Cassandro E.

Clin Genet. 2005 Aug;68(2):161-6.

PMID:
15996214
37.

MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.

Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, Nigro A, Noris P, Gangarossa S, Rocca B, Gresele P, Bizzaro N, Malatesta P, Koivisto PA, Longo I, Musso R, Pecoraro C, Iolascon A, Magrini U, Rodriguez Soriano J, Renieri A, Ghiggeri GM, Ravazzolo R, Balduini CL, Savoia A.

Medicine (Baltimore). 2003 May;82(3):203-15.

38.

Neuronal or glial progeny: regional differences in radial glia fate.

Malatesta P, Hack MA, Hartfuss E, Kettenmann H, Klinkert W, Kirchhoff F, Götz M.

Neuron. 2003 Mar 6;37(5):751-64.

39.
40.

Emx2 promotes symmetric cell divisions and a multipotential fate in precursors from the cerebral cortex.

Heins N, Cremisi F, Malatesta P, Gangemi RM, Corte G, Price J, Goudreau G, Gruss P, Götz M.

Mol Cell Neurosci. 2001 Nov;18(5):485-502.

PMID:
11922140
41.

Glial cells generate neurons: the role of the transcription factor Pax6.

Heins N, Malatesta P, Cecconi F, Nakafuku M, Tucker KL, Hack MA, Chapouton P, Barde YA, Götz M.

Nat Neurosci. 2002 Apr;5(4):308-15. Erratum in: Nat Neurosci 2002 May;5(5):500.

PMID:
11896398
42.

In vivo PC3 overexpression by retroviral vector affects cell differentiation of rat cortical precursors.

Malatesta P, Sgadò P, Caneparo L, Barsacchi G, Cremisi F.

Brain Res Dev Brain Res. 2001 Jun 29;128(2):181-5.

PMID:
11412904
43.

Prevention of pericardial adhesions with N-O carboxymethylchitosan in the rabbit model.

Krause TJ, Zazanis G, Malatesta P, Solina A.

J Invest Surg. 2001 Mar-Apr;14(2):93-7.

PMID:
11396625
44.

Isolation of radial glial cells by fluorescent-activated cell sorting reveals a neuronal lineage.

Malatesta P, Hartfuss E, Götz M.

Development. 2000 Dec;127(24):5253-63.

45.

PC3 overexpression affects the pattern of cell division of rat cortical precursors.

Malatesta P, Götz M, Barsacchi G, Price J, Zoncu R, Cremisi F.

Mech Dev. 2000 Jan;90(1):17-28.

46.

Characterization of a cloned xenopus laevis serotonin 5-HT1A receptor expressed in the NIH-3T3 cell line.

Cappellini C, Malatesta P, Costa B, Marracci S, Nardi I, Martini C.

Brain Res Mol Brain Res. 1999 Jan 8;63(2):380-3.

PMID:
9878840
47.

Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.

Perticone F, Ceravolo R, Cosco C, Trapasso M, Zingone A, Malatesta P, Perrotti N, Tramontano D, Mattioli PL.

J Am Coll Cardiol. 1997 Feb;29(2):365-9.

48.

The effects of hemodilution with polyethylene glycol bovine hemoglobin (PEG-Hb) in a conscious porcine model.

Conover CD, Malatesta P, Lejeune L, Chang CL, Shorr RG.

J Investig Med. 1996 Jun;44(5):238-46.

PMID:
8763974
49.

Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.

Cohen SM, Werrmann JG, Rasmusson GH, Tanaka WK, Malatesta PF, Prahalada S, Jacobs JG, Harris G, Nett TM.

Prostate. 1995 Feb;26(2):55-71.

PMID:
7531846
50.

Magnetic resonance imaging of the efficacy of specific inhibition of 5 alpha-reductase in canine spontaneous benign prostatic hyperplasia.

Cohen SM, Taber KH, Malatesta PF, Shpungin J, Berman C, Carlin JR, Werrmann JG, Prahalada S, Bryan RN, Cordes EH.

Magn Reson Med. 1991 Sep;21(1):55-70.

PMID:
1719333

Supplemental Content

Loading ...
Support Center